Latest filing published 12 Feb 2026 for HCA Healthcare, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Jennifer Berres in HCA Healthcare, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 5 November 2021 to 10 February 2026, the count stands at 9 filings.
Sales make up the whole of the open-market record (2 sales, €1.4M). Other entries cover 5 share grants and 2 option exercises.
The newest entry dates from 12 February 2026: a share grant, in HCA Healthcare, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations